Evidence map›Paper›PMID 15042374›Full record

ArticleHistochemistry and cell biology2004

Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.

Andrei L Kindzelskii, Imran Amhad, Donald Keller, M-J Zhou, Richard P Haugland, B A Garni-Wagner, Margaret R Gyetko, Robert F Todd, Howard R Petty

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Histochemistry and cell biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Protons make tumor cells move like clockwork.Pflugers Archiv : European journal of physiology · 2009
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. News and views in Histochemistry and Cell Biology.Histochemistry and cell biology · 2004
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Andrei L KindzelskiiDepartment of Ophthalmology and Visual Sciences and Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48105, USA.
Imran Amhad
Donald Keller
M-J Zhou
Richard P Haugland
B A Garni-Wagner
Margaret R Gyetko
Robert F Todd
Howard R Petty
University of Michigan–Ann Arbor · USAnn Arbor VA Medical Center · US

Funding

Signaling Dynamics of Leukocyte-Tumor Cell InteractionsR01CA074120 · NCI · WAYNE STATE UNIVERSITY · PI PETTY, HOWARD R · 1998 to 2008
$2.1M
CELL SURFACE ANTIGENS ON HUMAN MACROPHAGESR01CA039064 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, ROBERT F · 1985 to 1999
–
MACROPHAGE ACTIVATION ANTIGENSR01CA042246 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, ROBERT F · 1986 to 1998
–
NCI NIH HHS CA-39064NCI NIH HHS CA-42246NCI NIH HHS CA74120
6 · The paper itself

Abstract

Previous studies have shown that the urokinase-type plasminogen activator receptor (uPAR) is localized to the adherence sites of leukocytes and tumor cells suggesting that pericellular proteolysis may accompany focal activation of adherence. To assess for focused pericellular proteolytic activity, we prepared two-dimensional substrates coated with FITC-casein or Bodipy FL-BSA. These molecules are poorly fluorescent, but become highly fluorescent after proteolytic degradation. Fluorescent peptide products were observed at adherence sites of stationary human neutrophils and at lamellipodia of polarized neutrophils. During cell migration, multiple regions of proteolysis appeared sequentially beneath the cell. Similarly, proteolytic action was restricted to adherence sites of resting HT1080 tumor cells but localized to the invadopodia of active cells. Using an extracellular fluorescence quenching method, we demonstrate that these fluorescent peptide products are extracellular. The uPA/uPAR system played an important role in the observed proteolytic activation. Plasminogen activator inhibitor-1 significantly reduced focal proteolysis. Sites of focal proteolysis matched the membrane distribution of uPAR. When uPA was dissociated from uPAR by acid washing, substantially reduced pericellular proteolysis was found. uPAR-negative T47D tumor cells did not express significant levels of substrate proteolysis. However, transfectant clones expressing uPAR (for example, T47D-26) displayed high levels of fluorescence indicating proteolysis at adherence sites. To provide further evidence for the role of the uPA/uPAR system in pericellular proteolysis, peritoneal macrophages from uPA knock-out (uPA-/-) and control (uPA+/+) mice were studied. Pericellular proteolysis was dramatically reduced in uPA-negative peritoneal macrophages. Thus, we have: (1). developed a novel methodology to detect pericellular proteolytic function, (2). demonstrated focused activation of proteolytic enzymatic activity in several cell types, (3). demonstrated its usefulness in real-time studies of cell migration, and (4). showed that the uPA/uPAR system is an important contributor to focal pericellular proteolysis.

Indexed as

AnimalsCell AdhesionCell Line, TumorCells, CulturedEndopeptidasesFluorescent DyesFocal AdhesionsHumansLeukocytesMacrophages, PeritonealMiceMice, KnockoutNeoplasmsReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorUrokinase-Type Plasminogen ActivatorEndopeptidasesFluorescent DyesPLAUR protein, humanPlaur protein, mouseReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorUrokinase-Type Plasminogen Activator

Identifiers

PMID15042374
OpenAlexW2148885856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.